GO:0000030 mannosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000030 mannosyltransferase activity is a molecular function defined as the catalysis of mannosyl group transfer to an acceptor molecule, typically another carbohydrate or a lipid.
• Mannosyltransferases include protein O-mannosyltransferases, C-mannosyltransferases, dolichyl-phosphate mannose synthases, and α1,3-mannosyltransferases that modify glycoproteins, glycolipids, and glycans.
• Protein O-mannosylation is essential for sarcolemma resilience and skeletal muscle health through dystroglycan modification.
• DPM1, a mannosyltransferase, regulates the ER-stress sensor IRE1 in colorectal cancer, linking mannosyltransferase activity to tumor biology.
• Inhibiting α1,3-mannosyltransferase expression suppresses bladder cancer metastasis by reducing LRFN4 N-glycosylation.
• Mannosyltransferase activity can be studied using CRISPR knockout, point-mutation, knock-in, overexpression models, and target-based cell assays.
Description
Mannosyltransferase activity (GO:0000030) is a fundamental molecular function in glycobiology, defined as the catalysis of mannosyl group transfer to an acceptor molecule, typically another carbohydrate or a lipid. This activity is central to the biosynthesis of glycoproteins, glycolipids, and polysaccharides across all domains of life. In eukaryotes, protein O-mannosylation is initiated in the endoplasmic reticulum and is essential for the proper function of many secreted and membrane proteins. In bacteria such as Mycobacterium tuberculosis, protein-O-mannosyltransferases play critical roles in cell wall integrity and pathogenesis. The importance of mannosyltransferase activity extends to human disease: mutations or dysregulation in mannosyltransferase genes are associated with muscular dystrophies, cancer progression, and congenital disorders of glycosylation. Understanding the molecular mechanisms, key genes, and regulatory networks of mannosyltransferase activity is therefore essential for researchers in glycobiology, cancer biology, and drug discovery.
mannosyltransferase activity At A Glance
| GO ID | GO:0000030 |
|---|---|
| GO term | mannosyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Transfer of a mannosyl group to an acceptor molecule, typically another carbohydrate or a lipid |
| EC number | 2.4.1.- |
| Found in | Eukaryotes, bacteria, and archaea |
| Key substrates | GDP-mannose, dolichyl-phosphate-mannose, proteins, lipids, oligosaccharides |
| Related processes | Protein O-mannosylation, N-glycosylation, C-mannosylation, glycolipid biosynthesis |
What Is GO:0000030?
According to the Gene Ontology, GO:0000030 mannosyltransferase activity is defined as the catalysis of the transfer of a mannosyl group to an acceptor molecule, typically another carbohydrate or a lipid. This activity encompasses enzymes that use activated mannose donors, such as GDP-mannose or dolichyl-phosphate-mannose, to modify substrates including proteins, lipids, and oligosaccharides.
Why Is mannosyltransferase activity Important in Cell Biology?
Mannosyltransferase activity is essential for a wide range of biological processes, from protein folding and stability to cell wall biosynthesis and host-pathogen interactions. Defects in mannosyltransferase genes cause congenital muscular dystrophies and glycosylation disorders, while altered activity contributes to cancer metastasis and immune evasion. In Mycobacterium tuberculosis, protein-O-mannosyltransferases are potential drug targets because they are required for virulence and cell envelope integrity. Thus, understanding mannosyltransferase activity provides insights into fundamental glycobiology and offers therapeutic opportunities.
• Required for protein O-mannosylation of dystroglycan, which maintains sarcolemma resilience and skeletal muscle health.
• DPM1 mannosyltransferase regulates the ER-stress sensor IRE1 in colorectal cancer, influencing tumor cell survival.
• α1,3-mannosyltransferase expression supports bladder cancer metastasis through LRFN4 N-glycosylation.
• C-mannosyltransferase DPY19L3 promotes vasculogenic mimicry in tumors.
• Protein O-mannosylation is conserved from yeast to humans and is essential for cell wall integrity in fungi.
• Mycobacterium tuberculosis protein-O-mannosyltransferase is a target for novel anti-tuberculosis assays.
• Mannosyltransferase activity is critical for glycolipid and glycoprotein biosynthesis in all domains of life.
• Dysregulation of mannosyltransferases is linked to congenital disorders of glycosylation and muscular dystrophies.
• Target-based cell assays enable high-throughput screening for mannosyltransferase inhibitors.
• CRISPR-based models allow precise dissection of mannosyltransferase gene function in disease contexts.
What Happens During mannosyltransferase activity?
Substrate recognition and donor activation
In simple terms: The enzyme first grabs an activated mannose donor and holds it in place.
Mannosyltransferases use activated mannose donors such as GDP-mannose or dolichyl-phosphate-mannose. The enzyme binds the donor and the acceptor substrate in a defined orientation, ensuring specificity for the target hydroxyl or amino group.
Catalytic transfer of the mannosyl group
In simple terms: The enzyme then hands the mannose over to the acceptor molecule.
The catalytic mechanism involves the transfer of the mannosyl group from the donor to the acceptor, forming a glycosidic bond. This reaction is typically metal-ion independent but may require divalent cations for some family members.
Protein O-mannosylation in the endoplasmic reticulum
In simple terms: In the ER, mannose is attached to serine or threonine residues of proteins.
Protein O-mannosyltransferases (PMTs) catalyze the transfer of mannose to serine or threonine residues of secretory proteins. This modification is essential for protein folding, stability, and function, and is conserved from yeast to humans.
C-mannosylation of tryptophan residues
In simple terms: Some enzymes attach mannose directly to tryptophan in proteins.
C-mannosyltransferases such as DPY19L3 catalyze the attachment of mannose to the indole ring of tryptophan residues in proteins. This modification influences protein secretion and function, and has been linked to vasculogenic mimicry in cancer.
Dolichyl-phosphate mannose synthase and glycolipid biosynthesis
In simple terms: Other mannosyltransferases build lipid-linked mannose for glycan assembly.
DPM1 and related enzymes synthesize dolichyl-phosphate-mannose, a key intermediate in N-glycosylation and glycosylphosphatidylinositol anchor biosynthesis. DPM1 activity is also linked to ER stress regulation through IRE1.
Key Genes Involved in GO:0000030 mannosyltransferase activity
The following genes encode mannosyltransferases or mannosyltransferase-related proteins that have been experimentally characterized in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DPM1 | Dolichyl-phosphate mannose synthase subunit; catalyzes mannosyl transfer to dolichyl phosphate | Regulates ER-stress sensor IRE1 in colorectal cancer |
| DPY19L3 | C-mannosyltransferase that modifies tryptophan residues | Promotes vasculogenic mimicry in tumors |
| POMT1 | Protein O-mannosyltransferase 1; initiates O-mannosylation of dystroglycan | Mutations cause muscular dystrophies; essential for sarcolemma resilience |
| POMT2 | Protein O-mannosyltransferase 2; forms complex with POMT1 | Required for dystroglycan O-mannosylation and muscle health |
| PMT1 | Yeast protein O-mannosyltransferase | Model for studying diminished O-mannosyltransferase activity |
| PMT2 | Yeast protein O-mannosyltransferase | Functional consequences of reduced activity in baker's yeast |
| PMT4 | Yeast protein O-mannosyltransferase | Substrate specificity and cellular roles |
| ALG1 | Mannosyltransferase involved in N-glycan assembly | Congenital disorders of glycosylation |
| ALG2 | Mannosyltransferase in N-glycan processing | Glycosylation pathway research |
| ALG9 | Mannosyltransferase in glycosylphosphatidylinositol anchor biosynthesis | Inherited glycosylation defects |
| ALG12 | Mannosyltransferase in N-glycan synthesis | Congenital muscular dystrophy |
| Mtb Pmt | Mycobacterium tuberculosis protein-O-mannosyltransferase | Target for anti-tuberculosis drug development |
| α1,3-mannosyltransferase | Adds mannose to N-glycans on LRFN4 | Supports bladder cancer metastasis |
| DPM2 | Regulatory subunit of dolichyl-phosphate mannose synthase | Glycosylphosphatidylinositol anchor biosynthesis |
| DPM3 | Stabilizing subunit of dolichyl-phosphate mannose synthase | Muscular dystrophy and glycosylation disorders |
| POMGNT1 | O-mannose beta-1,2-N-acetylglucosaminyltransferase | Muscle-eye-brain disease |
| FKRP | Fukutin-related protein; ribitol-5-phosphate transferase | Dystroglycanopathies |
| LARGE1 | Xylosyl- and glucuronyltransferase | Modifies dystroglycan glycan; muscular dystrophy |
How Is mannosyltransferase activity Regulated?
Mannosyltransferase activity is regulated at multiple levels. In yeast, diminished protein O-mannosyltransferase activity triggers compensatory changes in cell wall integrity and ER homeostasis. In colorectal cancer, DPM1 expression and activity modulate the ER-stress sensor IRE1, linking mannosyltransferase function to the unfolded protein response. Additionally, α1,3-mannosyltransferase expression can be suppressed by nordihydroguaiaretic acid, indicating pharmacological regulation. The activity of protein O-mannosyltransferases is also influenced by substrate availability and complex formation with accessory proteins such as POMGNT1 and FKRP.
mannosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DPM1 | Colorectal cancer; ER stress regulation | Knockout and overexpression in HCT116 cells |
| DPY19L3 | Vasculogenic mimicry in tumors | Knockout in melanoma cell lines |
| POMT1/POMT2 | Congenital muscular dystrophy | Knockout in mouse myoblasts |
| α1,3-mannosyltransferase | Bladder cancer metastasis | Knockdown in bladder cancer cells |
| Mtb Pmt | Tuberculosis | Target-based cell assay in Mycobacterium tuberculosis |
Mannosyltransferase activity in cancer
DPM1 mannosyltransferase regulates IRE1 activity in colorectal cancer, affecting tumor cell survival under ER stress. α1,3-mannosyltransferase expression promotes bladder cancer metastasis by enhancing LRFN4 N-glycosylation, and its inhibition reduces metastatic potential. DPY19L3 C-mannosyltransferase activity supports vasculogenic mimicry, a process that contributes to tumor blood supply.
Mannosyltransferase activity in muscular dystrophies
O-mannosylation of dystroglycan by POMT1 and POMT2 is essential for sarcolemma resilience and skeletal muscle health. Defects in this pathway cause congenital muscular dystrophies with brain and eye abnormalities.
Mannosyltransferase activity in infectious disease
Mycobacterium tuberculosis protein-O-mannosyltransferase is required for cell envelope integrity and virulence. Target-based cell assays have been developed to screen for inhibitors of this enzyme, highlighting its potential as an anti-tuberculosis drug target.
Mannosyltransferase activity in glycosylation disorders
Mutations in mannosyltransferase genes such as ALG1, ALG2, ALG9, and ALG12 cause congenital disorders of glycosylation, leading to multisystemic clinical phenotypes.
From mannosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DPM1 affect IRE1 signaling in colorectal cancer? | DPM1 knockout HCT116 cells |
| Does DPY19L3 C-mannosyltransferase activity promote vasculogenic mimicry? | DPY19L3 knockout melanoma cells |
| Is POMT1 O-mannosylation required for sarcolemma resilience? | POMT1 knockout mouse muscle |
| Can α1,3-mannosyltransferase inhibition reduce bladder cancer metastasis? | α1,3-mannosyltransferase knockdown bladder cancer cells |
| Does Mycobacterium tuberculosis Pmt require a WW-domain-like motif for activity? | Point mutations in Mtb Pmt |
| Can diminished O-mannosyltransferase activity be compensated in yeast? | PMT deletion mutants in Saccharomyces cerevisiae |
How to Study the mannosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Target-based cell assay | Mannosyltransferase activity in live cells | High-throughput inhibitor screening |
| CRISPR knockout | Loss-of-function phenotypes | Cancer cell line studies |
| Glycoproteomics | Mannosylated protein identification | Mapping O-mannosylation sites |
| Site-directed mutagenesis | Enzyme structure-function relationships | Testing catalytic residues |
| qRT-PCR | Mannosyltransferase gene expression | Cancer biomarker analysis |
| Western blot | Protein expression and modification | Dystroglycan O-mannosylation |
| Yeast genetics | Growth and cell wall integrity | PMT gene deletion studies |
| Immunofluorescence | Subcellular localization | ER and Golgi localization of mannosyltransferases |
Target-based cell assays for mannosyltransferase activity
Reporter-based cell assays have been developed to measure Mycobacterium tuberculosis protein-O-mannosyltransferase activity, enabling high-throughput screening of inhibitors.
CRISPR knockout and knockdown studies
CRISPR-Cas9 knockout of mannosyltransferase genes such as DPM1 and DPY19L3 allows functional studies in cancer cell lines, revealing roles in ER stress and vasculogenic mimicry.
Glycoproteomics and mass spectrometry
Mass spectrometry-based glycoproteomics can identify mannosylated proteins and quantify changes in O-mannosylation and C-mannosylation upon genetic or pharmacological perturbation.
Structural biology and mutational analysis
Structural insights into Mycobacterium tuberculosis protein mannosyltransferase have revealed a WW-domain-like motif, and point mutations can test its functional importance.
How CRISPR Can Be Used to Study GO:0000030 mannosyltransferase activity
Knockout
CRISPR knockout of mannosyltransferase genes such as DPM1 and DPY19L3 enables loss-of-function studies to determine their roles in ER stress regulation and tumor vasculogenic mimicry.
Point Mutation
Point mutations can be introduced into catalytic residues or regulatory motifs of mannosyltransferases, such as the WW-domain-like motif in Mycobacterium tuberculosis Pmt, to dissect structure-function relationships.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous mannosyltransferase loci allows real-time tracking of enzyme localization and activity in living cells.
Overexpression
Overexpression of mannosyltransferases such as α1,3-mannosyltransferase or DPM1 can model gain-of-function phenotypes in cancer metastasis and ER stress adaptation.
How EDITGENE Supports mannosyltransferase activity Research
Researchers studying mannosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in glycosylation, cancer progression, or muscular dystrophy. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for mannosyltransferase activity research.
Frequently Asked Questions About mannosyltransferase activity
What is mannosyltransferase activity?
Mannosyltransferase activity (GO:0000030) is the catalysis of the transfer of a mannosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
What genes are involved in mannosyltransferase activity?
Key genes include DPM1, DPY19L3, POMT1, POMT2, ALG1, ALG2, ALG9, ALG12, and the yeast PMT genes.
What diseases are associated with mannosyltransferase activity?
Mannosyltransferase defects are linked to colorectal cancer, bladder cancer, congenital muscular dystrophies, glycosylation disorders, and tuberculosis.
How is mannosyltransferase activity regulated?
It is regulated by substrate availability, complex formation with accessory proteins, ER stress signaling, and pharmacological inhibitors such as nordihydroguaiaretic acid.
What is the role of DPM1 in cancer?
DPM1 mannosyltransferase regulates the ER-stress sensor IRE1 in colorectal cancer, affecting tumor cell survival.
How does O-mannosylation affect muscle health?
O-mannosylation of dystroglycan by POMT1 and POMT2 is essential for sarcolemma resilience and skeletal muscle health.
Can mannosyltransferase activity be inhibited for therapy?
Yes, target-based cell assays have been developed to screen for inhibitors of Mycobacterium tuberculosis protein-O-mannosyltransferase, and nordihydroguaiaretic acid inhibits α1,3-mannosyltransferase.
What methods are used to study mannosyltransferase activity?
Methods include target-based cell assays, CRISPR knockout, glycoproteomics, site-directed mutagenesis, and yeast genetics.
What is the difference between O-mannosylation and C-mannosylation?
O-mannosylation attaches mannose to serine or threonine residues, while C-mannosylation attaches mannose to tryptophan residues.
How can CRISPR help study mannosyltransferase genes?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise functional dissection of mannosyltransferase genes in disease contexts.
Conclusion
Mannosyltransferase activity (GO:0000030) is a fundamental molecular function with critical roles in protein glycosylation, cell wall biosynthesis, and human disease. From cancer progression to muscular dystrophy and tuberculosis, mannosyltransferases represent important research targets and therapeutic opportunities. Advances in CRISPR-based models and glycoproteomics will continue to illuminate the mechanisms and regulation of this essential enzyme family.
References
- 1. Issaoui H et al.. 2026. The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.. Nat Commun 17(1) PMID: 42230629
- 2. Baydoun H et al.. 2024. DPY19L3 promotes vasculogenic mimicry by its C-mannosyltransferase activity.. Oncol Res 32(4):607-614 PMID: 38560568
- 3. Strahl-Bolsinger S et al.. 1999. Protein O-mannosylation.. Biochim Biophys Acta 1426(2):297-307 PMID: 9878797
- 4. Géraud N et al.. 2023. Development of a novel target-based cell assay, reporter of the activity of Mycobacterium tuberculosis protein-O-mannosyltransferase.. Glycobiology 33(12):1139-1154 PMID: 37698262
- 5. Liu M et al.. 2025. Nordihydroguaiaretic acid inhibits bladder cancer metastasis through suppression of α1,3-mannosyltransferase expression and LRFN4 N-glycosylation.. J Transl Med 23(1):733 PMID: 40605099
- 6. Hord JM et al.. 2025. Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan.. Skelet Muscle 15(1):1 PMID: 39789642
- 7. Géraud N et al.. 2025. Structural Insights into the Protein Mannosyltransferase from Mycobacterium tuberculosis reveal a WW-Domain-Like Protein Motif in Bacteria.. Commun Biol 8(1):1175 PMID: 40775265
- 8. Zatorska E et al.. 2017. Cellular Consequences of Diminished Protein O-Mannosyltransferase Activity in Baker's Yeast.. Int J Mol Sci 18(6) PMID: 28598353
